- Organization Overview
- Dean’s Office
- Dean’s Office Overview
- PharmD Education Unit
- Office of Faculty Academic Affairs
- Office of Administration
- Pharmacy Practice Partnerships
- Department of Bioengineering and Therapeutic Sciences
- Department of Clinical Pharmacy
- Department of Pharmaceutical Chemistry
- Quantitative Biosciences Institute
- Org Chart
- Patient Care
Kuntz receives Volwiler Award
By UCSF School of Pharmacy Editorial Staff / Fri Apr 4, 2003
Irwin (Tack) D. Kuntz, PhD, professor, Department of Pharmaceutical Chemistry, UCSF School of Pharmacy has been named the 2003 Volwiler Research Achievement Award recipient by the American Association of Colleges of Pharmacy (AACP).
The award is presented annually in recognition of outstanding achievement by an AACP pharmacy educator. Kuntz is an internationally recognized scientist known for his seminal work in computational approaches to drug design, protein structure, and macromolecule-ligand interactions.
He was the first to develop a computer-based molecular docking software program, called DOCK, that calculates and displays in 3 dimensions how potential drugs might attach to target molecules. Computer-based approaches speed drug development by more efficiently "sorting out" or "screening" from millions, and billions, of chemicals those compounds that have the best potential for drug development. The DOCK algorithm is widely used by researchers in academia, pharmaceutical firms, and the biotechnology industry.
Kuntz will be present to receive the Volwiler Award in a ceremony on July 22, 2003 at the AACP annual meeting awards banquet held in Minneapolis, Minnesota, USA. For more information, see Volwiler Research Achievement Award.
School of Pharmacy, Department of Pharmaceutical Chemistry, PharmD Degree Program, QBC, CCB, Biophysics
About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.